A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).
Laack E, Thöm I, Krüll A, Engel-Riedel W, Müller T, Meissner C, Dürk H, Fischer J, Gütz S, Kortsik C, Elbers M, Schuch G, Andritzky B, Görn M, Burkholder I, Edler L, Hossfeld DK, Bokemeyer C.
Laack E, et al. Among authors: andritzky b.
Lung Cancer. 2007 Aug;57(2):181-6. doi: 10.1016/j.lungcan.2007.03.001. Epub 2007 Apr 17.
Lung Cancer. 2007.
PMID: 17442447
Clinical Trial.